Brief: Natco Pharma Launches Semaglutide Generic Injection Multi Dose Vials In India
20/03/2026 04:08
March 20 (Reuters) - Natco Pharma Ltd NATP.NS: NATCO PHARMA - LAUNCHES SEMAGLUTIDE GENERIC INJECTION MULTI DOSE VIALS IN INDIA NATCO PHARMA - MULTI DOSE VIALS LAUNCHED AT 1,290 RUPEES AND 1,750 RUPEES PER MONTH NATCO PHARMA - PEN DEVICE PRICED AT 4,000 RUPEES AND 4500 RUPEES PER MONTH, LAUNCH EXPECTED APRIL 2026 Source text: ID:nNSE2S1pW8 Further company coverage: NATP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees